66) Recently, bile acids and the bile acid receptor FXR have been implicated in |
67) somnia medications are gamma-aminobutylic acid receptor agonists. |
68) ve effects, including gamma amino butyric acid receptor antagonists and multiple pes |
69) coupled receptor (GPR) 40 is a free fatty acid receptor mainly expressed in pancreat |
70) crease the anticancer efficacy of Ursolic Acid in terms of several parameters includ |
71) 5 min) as well as 5% trichloroacetic acid in CH2Cl2 (3 × 2 min) enabled M |
72) Data from the Tranexamic acid in IntraCerebral Hemorrhage-2 (TICH-2 |
73) instillation of 2 ml of (4% v/v) acetic acid in normal saline using a pediatric pl |
74) valuate the biological action of valproic acid in the acetylation of histones and in |
75) us biomarkers demonstrated that kynurenic acid in the plasma offers promise as a sup |
76) consisted of acetonitrile and 0.1% acetic acid in water with a total flow of 0.37 mL |
77) quinolines and cis-(+)-12-oxophytodienoic acid, in synergy, could act as anticancer |
78) rane expression of ASIC1a, and five amino acid residues (AA 16-20) are involved in t |
79) Several amino acid residues around the dicopper active c |
80) The deletion of three or five amino acid residues in the linker region resulte |
81) in sequence similarity and critical amino acid residues obtained by the Sequence Ali |
82) nic anions of ILs bound to specific amino acid residues of AChE through noncovalent |
83) ificant, with no single or group of amino acid residues playing a decisive role in r |
84) eractions with multiple active site amino acid residues. |
85) ogenase enzymes involved in tricarboxylic acid cycle (TCA) cycle thereby directly co |
86) he mitochondria through the tricarboxylic acid cycle (TCA), the requirement of prope |
87) iotic-mediated induction of tricarboxylic acid cycle activity, thus avoiding metabol |
88) uccinate to fumarate in the tricarboxylic acid cycle and the electrons are used to r |
89) f cells, glycolysis and the tricarboxylic acid cycle. |
90) cis-aconitate away from the tricarboxylic acid cycle. |
91) a heterodimeric complex with L-type amino acid transporter 1 (LAT1) and transports l |
92) L-type amino acid transporter 2 (LAT2) is a Na+-indepen |
93) ses the blood-brain barrier via the amino acid transporter LAT1 (SLC7A5) after which |
94) function of apical sodium-dependent bile acid transporter and sodium/taurocholate c |
95) ixibat, an oral small-molecule ileal bile acid transporter inhibitor under developme |
96) α/β (OSTα/β) is a bidirectional bile acid transporter localized on the basolate |
97) HDAC8 inhibition by hexanoic and decanoic acid was also examined. |
98) Plasma myristic acid was also inversely associated with co |
add keyword